Drug-resistant TB patients lost in the system
Multidrug-resistant (MDR) TB is resistant to the most commonly used first-line TB drugs. Extensively drug-resistant (XDR-TB) is resistant to these drugs as well as at least half of the mostly commonly used second-line drugs.
Jessica Grootboom* from Secunda was diagnosed with MDR-TB in May 2013, and says life has not been the same.MDR-TB can take about two years to treat.
After four months of MDR-TB treatment, Grootboom says a social worker informed her that she had XDR-TB.
There was no explanation from nurses, and she says she is not sure if she developed additional resistance or was initially misdiagnosed.
“I don’t think I ever had MDR-TB,” she tells Health-e News. “I think the nurses were not responsible enough to check on my results on time so that they’d pick up any changes.”
Although she has been told she has XDR-TB, Grootboom says she continues to take the same medication she was prescribed as an MDR-TB patient.
“I don’t know if I am suppose to be taking all this medication,” she said. “I just need clarity on why do I still get given MDR treatment whereas I have XDR.”
While some MDR-TB drugs may work for some XDR-TB patients, national guidelines say that XDR-TB treatment regimens must be individually tailored for patients. MDR-TB patients who are newly diagnosed as having XDR-TB should see changes to their treatment regimen.
National policy also dictates that patients must be fully informed about their conditions before being transferred to specialist facilities.
According to Mpumalanga Department of Health spokesperson Dumisani Malamule MDR-TB patients must also sign informed consent forms that outlines treatment side effects before being initiated on treatment. They also receive counseling by professional nurses, medical officers, social workers and treatment supporters, he added.
He said it was unlikely that patients were recieving incorrect treatment given that clinicians should be following guidelines.
Grootboom takes about 21 pills a day in her bid to stay alive. Once a month, she must wake up at 4am to catch a bus to collect her drugs at Witbank Hospital and has been given the wrong medicine in the past.
Poor treatment causes patient revolt[quote float=”right”]“I was distraught and crying and I didn’t want to be admitted, and the ambulance had just left me there”
Problems are not confined to the province’s Standerton TB Specialist Hospital, according to Patience Moshidi, who was diagnosed with TB in 2010 but failed to respond to treatment.
When health care workers at Nelspruit’s Civic Centre Clinic allegedly failed to help her, Moshidi consulted private doctors who diagnosed her with MDR-TB. She was told she would need to be transferred by ambulance to the public sector Barberton TB Specialised Hospital for treatment. It was the beginning of a nightmare.
“I didn’t want to be admitted to the hospital because I had lost my faith in the public health people,” she said. “I felt like I was being dumped somewhere to die.”
Her induction at Barberton was surreal and frightening. Like other Standerton patients, she reports that nurses did nothing to explain to her what MDR-TB was or what treatment entailed.
“I wanted to understand but nothing was being explained to me and I was not orientated about the disease,” she said. “I was distraught and crying and I didn’t want to be admitted, and the ambulance had just left me there.”
She also alleged that poor conditions in the ward, including rusty equipment and abysmal food, led her to petition nurses on behalf of patients. It was not well received, she tells Health-e News Service.
“You live the entire time scared,” said Moshidi remembering her time in the ward. “You’re waiting to see who’s going to die next…(patients) went into panic mode and believed that this thing doesn’t get cured.”
Moshidi was discharged in April 2013 but in January, she received the results of an October 2013 test that showed her MDR-TB had returned.
Additional reporting by Laura Lopez Gonzalez
Read more on Mpumalanga’s health crisis as part of Health’e News’ “Deadly debt” series:
Author
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
-
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
-
You must include all of the links from our story, including our newsletter sign up link.
-
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
-
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
-
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
-
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
-
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Drug-resistant TB patients lost in the system
by ayandamkhwanazi, Health-e News
August 22, 2014